Leucine Rich Repeat and Fibronectin Type III Domain Containing 5 (LRFN5) (C-Term) Peptide
LRFN5
Reactivity: Human
BP
Sodium azide
-
- Target See all LRFN5 products
- LRFN5 (Leucine Rich Repeat and Fibronectin Type III Domain Containing 5 (LRFN5))
- Protein Region
- C-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
14 amino acids near the carboxy terminus of human LRFN5.
Human
-
-
- Application Notes
- LRFN5 peptide is used for blocking the activity of LRFN5.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- LRFN5 (Leucine Rich Repeat and Fibronectin Type III Domain Containing 5 (LRFN5))
- Synonyms
- C14orf146 Peptide, FIGLER8 Peptide, SALM5 Peptide, AI427653 Peptide, AI604817 Peptide, C130061B21 Peptide, mKIAA4208 Peptide, leucine rich repeat and fibronectin type III domain containing 5 Peptide, LRFN5 Peptide, Lrfn5 Peptide
-
You are here:
